Miguel Granell
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Outpatient Rescue With Stem Cells Boost for Refractory Hematotoxicity Following anti-BCMA CAR T-Cell Therapy: A Case Report.
Journal: Case reports in hematology
Published: October 13, 2025
Real-World Evidence Supports Venetoclax as an Additional Option for Patients With t(11;14) Myeloma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 26, 2025
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma.
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma.
Journal: Blood cancer journal
Published: January 11, 2022
Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group.
Journal: Blood cancer journal
Published: December 22, 2021
Do Patients and Physicians Agree When They Assess Quality of Life?
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: December 14, 2016
Elotuzumab in combination with thalidomide and low-dose dexamethasone: a phase 2 single-arm safety study in patients with relapsed/refractory multiple myeloma.
Journal: British journal of haematology
Published: March 22, 2016
Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations.
Journal: Leukemia research reports
Published: June 03, 2015
Degree of mucositis and duration of neutropenia are the major risk factors for early post-transplant febrile neutropenia and severe bacterial infections after reduced-intensity conditioning.
Journal: European journal of haematology
Published: October 26, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026